Shopping Cart
Remove All
Your shopping cart is currently empty
BND-35 is a human monoclonal antibody (mAb) that targets LILRB4/ILT3/CD85k. It interferes with the interaction between ILT3 and APOE as well as fibronectin, thereby enhancing the pro-inflammatory activity of various myeloid cells and reversing T cell immunosuppression mediated by different inhibitory myeloid cells. BND-35 exhibits antitumor activity in hILT3 transgenic mouse tumor models.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | BND-35 is a human monoclonal antibody (mAb) that targets LILRB4/ILT3/CD85k. It interferes with the interaction between ILT3 and APOE as well as fibronectin, thereby enhancing the pro-inflammatory activity of various myeloid cells and reversing T cell immunosuppression mediated by different inhibitory myeloid cells. BND-35 exhibits antitumor activity in hILT3 transgenic mouse tumor models. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | LILRB4/IL-T3/CD85k |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.